Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial

Christopher Parker, Steven E Finkelstein, Jeff M Michalski, Joe M O'Sullivan, Øyvind Bruland, Nicholas J Vogelzang, Robert E Coleman, Sten Nilsson, Oliver Sartor, Rui Li, Monica A Seger, David Bottomley

Research output: Contribution to journalArticlepeer-review

47 Citations (Scopus)
178 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences